Hematopoietic tumors
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients To Undergo Allogeneic Hematopoietic Stem-Cell Transplantation In Nagoya Universty Hospital Who Ware Obtained Written Informed Consent After a Full Explanation Of The Study
Exclusion criteria
Exclusion criteria: Patients Who can Not Understand Japanese Patients Who can Not Understand The Explanation Of The Study With Dementia, Disturbance of Consciousness and Psychiatric Desorders Patients Who Do Not Consent The Study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Delirium Rating Scale -R-98 (DRS-R-98) Memorial Delirium Assessment Scale (MDAS) Structured Clinical Interview for DSM-IV (SCID) Patient Health Questionnaire-9 (PHQ-9) | — |
Secondary
| Measure | Time frame |
|---|---|
| Hospital Anxiety and Depression Scale (HADS) Visual Analog Scale (VAS) 36-item Short-Form Health Survey (SF-36) Functional Assessment of Cancer Therapy Bone Marrow Transplant (FACT-BMT) Brief Evaluation of Medication Influence and Beliefs (BEMIB) Social Support Questionnaire (SSQ) Temperament and Character Inventory-125 (TCI-125) | — |
Countries
Japan
Contacts
Nagoya University Graduate School Of Medicine Department of Psyichiatry